Crinetics Pharmaceuticals Inc logo

Crinetics Pharmaceuticals Inc

NAS:CRNX (USA)  
$ 40.95 -1.82 (-4.26%) 10:09 PM EST
At Loss
P/B:
5.21
Volume:
1.35M
Avg Vol (2M):
665.25K
Also Trade In:
Volume:
1.35M
At Loss
Avg Vol (2M):
665.25K

Business Description

Description
Crinetics Pharmaceuticals Inc is a clinical-stage pharmaceutical company focused on the discovery, development, and commercialization of novel therapeutics for rare endocrine diseases and endocrine-related tumors.
Name Current Vs Industry Vs History
Cash-To-Debt 10.63
Equity-to-Asset 0.85
Debt-to-Equity 0.1
Debt-to-EBITDA -0.25
Interest Coverage N/A
N/A
N/A
Piotroski F-Score 2/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score 16.96
Distress
Grey
Safe
Beneish M-Score 2.6
Manipulator
Not Manipulator
WACC vs ROIC
WACC
ROIC
Name Current Vs Industry Vs History
5-Day RSI 64.3
9-Day RSI 63.35
14-Day RSI 61.86
6-1 Month Momentum % 110.62
12-1 Month Momentum % 85.74

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 14.23
Quick Ratio 14.23
Cash Ratio 13.71

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -30.5
Shareholder Yield % -0.42

Profitability Rank

Name Current Vs Industry Vs History
Operating Margin % -4394.45
Net Margin % -4223.27
FCF Margin % -3537.19
ROE % -56.98
ROA % -50.21
ROIC % -647.86
ROC (Joel Greenblatt) % -1346.36
ROCE % -56.57

Financials (Next Earnings Date:2024-02-28)

CRNX's 30-Y Financials
Income Statement Breakdown
No Enough Data
Balance Sheet Breakdown
No Enough Data
Cashflow Statement Breakdown
No Enough Data

Historical Operating Revenue by Business Segment

Historical Operating Revenue by Geographic Region

5-Step DuPont Analysis as of
No Enough Data

Guru Trades

See Details
To

Insider Trades

See Details
To

Gurus Latest Trades with NAS:CRNX

No Available Data

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
Log
Bar
To

Annualized Return %  

Symbol
1 Week
1 Month
3 Months
6 Months
YTD
1 Year
3 Years
5 Years
10 Years

Total Annual Return %  

Symbol
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015

Crinetics Pharmaceuticals Inc Executives

Details

Valuation Chart

Year:

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil $) 4.722
EPS (TTM) ($) -3.64
Beta 0.06
Volatility % 81.16
14-Day RSI 61.86
14-Day ATR ($) 2.230553
20-Day SMA ($) 38.10275
12-1 Month Momentum % 85.74
52-Week Range ($) 15.23 - 47.48
Shares Outstanding (Mil) 66.8

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 2
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Crinetics Pharmaceuticals Inc Filings

Filing Date Document Date Form
No Filing Data

Crinetics Pharmaceuticals Inc Stock Events

Financials Calendars
Event Date Price($)
No Event Data

Crinetics Pharmaceuticals Inc Frequently Asked Questions

What is Crinetics Pharmaceuticals Inc(CRNX)'s stock price today?
The current price of CRNX is $40.95. The 52 week high of CRNX is $47.48 and 52 week low is $15.23.
When is next earnings date of Crinetics Pharmaceuticals Inc(CRNX)?
The next earnings date of Crinetics Pharmaceuticals Inc(CRNX) is 2024-02-28.
Does Crinetics Pharmaceuticals Inc(CRNX) pay dividends? If so, how much?
Crinetics Pharmaceuticals Inc(CRNX) does not pay dividend.

Press Release

Subject Date
No Press Release

Headlines

See More
  • 1
No news.
  • 1